Inhibrx Biosciences (INBX) EBITDA (2023 - 2025)
Inhibrx Biosciences (INBX) reported EBITDA of -$30.9 million for Q4 2025, up 38.06% year-over-year from -$22.4 million in Q4 2024, and up 8.54% quarter-over-quarter from -$33.8 million in Q3 2025.
Inhibrx Biosciences (INBX) EBITDA (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of EBITDA data on file, last reported at -$30.9 million in Q4 2025.
- EBITDA for Q4 2025 came in at -$30.9 million, up 38.06% year-over-year; the trailing twelve-month figure through Dec 2025 was -$135.0 million (up 59.26% YoY), and the FY2025 annual result was -$135.0 million, up 59.26% from the prior year.
- EBITDA improved to -$30.9 million in Q4 2025 per INBX's latest filing, from -$33.8 million in the prior quarter.
- Over five years, EBITDA peaked at -$27.4 million in Q2 2025 and troughed at -$160.9 million in Q2 2024.
- A 3-year average of -$58.4 million and a median of -$45.8 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2025: EBITDA plunged 289.22% in 2024, then jumped 82.98% in 2025.
- A 3-year view of EBITDA shows it stood at -$88.3 million in 2023, then soared by 43.45% to -$49.9 million in 2024, then jumped by 38.06% to -$30.9 million in 2025.
- Business Quant data shows INBX's EBITDA at -$30.9 million in Q4 2025, -$33.8 million in Q3 2025, and -$27.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | -30.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.92 Mn |
| Sep 30, 2025 | -33.81 Mn |
| Jun 30, 2025 | -27.39 Mn |
| Mar 31, 2025 | -42.90 Mn |
| Dec 31, 2024 | -49.93 Mn |
| Sep 30, 2024 | -46.80 Mn |
| Jun 30, 2024 | -160.90 Mn |
| Mar 31, 2024 | -73.83 Mn |
| Dec 31, 2023 | -88.29 Mn |
| Sep 30, 2023 | -45.83 Mn |
| Jun 30, 2023 | -41.34 Mn |